Sembragiline

N/A

Report date: 2022/07/04 19:38:02
NME

Base Information

Drug NameSembragiline
Drug Alias Name森布吉兰sembragilinum赛博吉兰sembragilinaRO-4602522 +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMonoamine oxidase B inhibitors
TargetsMonoamine oxidase B
Therapy Area/IndicationsSmoking CessationAlzheimer Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[13] 
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesF. Hoffmann-La Roche Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesF. Hoffmann-La Roche LtdEvotec Neurosciences Gmbh
Active IndicationsN/A
Inactive IndicationsSmoking CessationAlzheimer Disease

Other Information

ATC CodeN/A
Related LinksN/A